UPDATE 1-Early data promising for AstraZeneca cancer drug combination By: Reuters: Company News September 27, 2014 at 07:45 AM EDT * MEDI4736, tremelimumab combination tested in lung cancer Read More >> Related Stocks: Astrazeneca Plc ADR Bristol-Myers Squibb Merck & Co Pfizer Rogers Corp